This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Cardiovascular Systems Management
Management Kriterienprüfungen 3/4
Wichtige Informationen
Scott Ward
Geschäftsführender
US$4.3m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 16.1% |
| Amtszeit als Geschäftsführer | 6.7yrs |
| Eigentum des Geschäftsführers | 1.9% |
| Durchschnittliche Amtszeit des Managements | 3.9yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 6.2yrs |
Jüngste Management Updates
Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05
Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Recent updates
We're Not Very Worried About Cardiovascular Systems' (NASDAQ:CSII) Cash Burn Rate
Feb 03We're Hopeful That Cardiovascular Systems (NASDAQ:CSII) Will Use Its Cash Wisely
Oct 12Cardiovascular Systems reports Q4 earnings miss; provides FY23 revenue guidance in-line with estimates
Aug 03Here's Why Cardiovascular Systems, Inc.'s (NASDAQ:CSII) CEO Compensation Is The Least Of Shareholders' Concerns
Nov 05Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 36%?
Oct 09At US$36.59, Is It Time To Put Cardiovascular Systems, Inc. (NASDAQ:CSII) On Your Watch List?
Sep 18Are Investors Undervaluing Cardiovascular Systems, Inc. (NASDAQ:CSII) By 28%?
Jun 24Is Now The Time To Look At Buying Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Jun 03We're Interested To See How Cardiovascular Systems (NASDAQ:CSII) Uses Its Cash Hoard To Grow
Apr 29Should You Take Comfort From Insider Transactions At Cardiovascular Systems, Inc. (NASDAQ:CSII)?
Mar 17Cardiovascular Systems (NASDAQ:CSII) Shareholders Have Enjoyed A Whopping 399% Share Price Gain
Feb 10Cardiovascular Systems misses on revenue
Feb 03Need To Know: Cardiovascular Systems, Inc. (NASDAQ:CSII) Insiders Have Been Selling Shares
Dec 11
Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
Nov 06Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Dec 31 2022 | n/a | n/a | -US$38m |
| Sep 30 2022 | n/a | n/a | -US$39m |
| Jun 30 2022 | US$4m | US$699k | -US$37m |
| Mar 31 2022 | n/a | n/a | -US$33m |
| Dec 31 2021 | n/a | n/a | -US$29m |
| Sep 30 2021 | n/a | n/a | -US$20m |
| Jun 30 2021 | US$4m | US$665k | -US$13m |
| Mar 31 2021 | n/a | n/a | -US$23m |
| Dec 31 2020 | n/a | n/a | -US$20m |
| Sep 30 2020 | n/a | n/a | -US$24m |
| Jun 30 2020 | US$5m | US$628k | -US$27m |
| Mar 31 2020 | n/a | n/a | -US$11m |
| Dec 31 2019 | n/a | n/a | -US$7m |
| Sep 30 2019 | n/a | n/a | -US$3m |
| Jun 30 2019 | US$5m | US$670k | -US$255k |
| Mar 31 2019 | n/a | n/a | US$2m |
| Dec 31 2018 | n/a | n/a | US$2m |
| Sep 30 2018 | n/a | n/a | US$782k |
| Jun 30 2018 | US$3m | US$650k | US$2m |
| Mar 31 2018 | n/a | n/a | -US$1m |
| Dec 31 2017 | n/a | n/a | -US$3m |
| Sep 30 2017 | n/a | n/a | -US$2m |
| Jun 30 2017 | US$4m | US$630k | -US$2m |
| Mar 31 2017 | n/a | n/a | -US$7m |
| Dec 31 2016 | n/a | n/a | -US$28m |
| Sep 30 2016 | n/a | n/a | -US$45m |
| Jun 30 2016 | US$908k | US$363k | -US$56m |
Vergütung im Vergleich zum Markt: Scott's total compensation ($USD4.34M) is about average for companies of similar size in the US market ($USD3.84M).
Entschädigung vs. Einkommen: Scott's compensation has increased whilst the company is unprofitable.
Geschäftsführer
Scott Ward (62 yo)
6.7yrs
Amtszeit
US$4,344,399
Vergütung
Mr. Scott Raymond Ward, MS, B.Sc., has been the Chief Executive Officer and President of Cardiovascular Systems Inc. since August 15, 2016 and served as an Interim Chief Executive Officer and Interim Presi...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman | 6.7yrs | US$4.34m | 1.92% $ 16.2m | |
| Chief Financial Officer | 5.2yrs | US$1.32m | 0.41% $ 3.5m | |
| General Counsel & Corporate Secretary | 8.4yrs | US$1.11m | 0.35% $ 3.0m | |
| Chief Compliance Officer | 5.8yrs | US$943.21k | 0.27% $ 2.3m | |
| Vice President of Quality & Operations | 1.3yrs | keine Daten | keine Daten | |
| Vice President of Investor Relations & Corporate Communications | no data | keine Daten | keine Daten | |
| Vice President of Marketing | 1.3yrs | keine Daten | keine Daten | |
| Vice President of US Sales | 1.3yrs | keine Daten | keine Daten | |
| Chief Human Resources Officer | 3.9yrs | keine Daten | 0.20% $ 1.7m | |
| Chief Medical Officer | 1.1yrs | keine Daten | keine Daten |
3.9yrs
Durchschnittliche Betriebszugehörigkeit
54yo
Durchschnittliches Alter
Erfahrenes Management: CSII's management team is considered experienced (3.9 years average tenure).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman | 9.4yrs | US$4.34m | 1.92% $ 16.2m | |
| Lead Independent Director | 14.2yrs | US$241.64k | 0.072% $ 606.8k | |
| Independent Director | 8.2yrs | US$200.00k | 0.022% $ 189.0k | |
| Independent Director | 6.2yrs | US$220.00k | 0.029% $ 248.2k | |
| Independent Director | 2.7yrs | US$200.00k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$210.00k | 0.0017% $ 14.0k | |
| Independent Director | 3.4yrs | US$212.00k | 0.0075% $ 63.0k |
6.2yrs
Durchschnittliche Betriebszugehörigkeit
62yo
Durchschnittliches Alter
Erfahrener Vorstand: CSII's board of directors are considered experienced (6.2 years average tenure).